Jackson Hole Capital Partners LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 33,000 shares of the company’s stock, valued at approximately $589,000.
Other hedge funds also recently modified their holdings of the company. FNY Investment Advisers LLC acquired a new position in shares of Grail during the 4th quarter valued at $26,000. Lindbrook Capital LLC acquired a new position in shares of Grail in the 4th quarter worth $28,000. New York State Common Retirement Fund acquired a new position in shares of Grail in the 4th quarter worth $59,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Grail in the 4th quarter worth $64,000. Finally, PNC Financial Services Group Inc. acquired a new position in shares of Grail in the 4th quarter worth $86,000.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on GRAL shares. Morgan Stanley started coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target on the stock. Wolfe Research started coverage on Grail in a report on Friday, November 15th. They set a “peer perform” rating on the stock.
Grail Trading Down 1.7 %
Shares of GRAL stock opened at $32.88 on Friday. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99. The stock’s fifty day simple moving average is $30.64 and its 200-day simple moving average is $20.84.
Grail (NASDAQ:GRAL – Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Equities analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.
Grail Company Profile
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Stories
- Five stocks we like better than Grail
- How to Most Effectively Use the MarketBeat Earnings Screener
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Find and Profitably Trade Stocks at 52-Week Lows
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- With Risk Tolerance, One Size Does Not Fit All
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL – Free Report).
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.